These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33677934)

  • 21. Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts.
    Craig S; Khalil M; Eszlinger M; Itani D; Koebel M; Koro K; Minoo P; Ogilvie T; Stewardson P; Teman C; Ziehr B; Pasieka JL
    Surgery; 2021 Jan; 169(1):22-26. PubMed ID: 32471652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    Giani C; Torregrossa L; Ramone T; Romei C; Matrone A; Molinaro E; Agate L; Materazzi G; Piaggi P; Ugolini C; Basolo F; Ciampi R; Elisei R
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4072-e4083. PubMed ID: 34231847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
    Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF
    Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK
    Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An International Interobserver Variability Reporting of the Nuclear Scoring Criteria to Diagnose Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: a Validation Study.
    Thompson LDR; Poller DN; Kakudo K; Burchette R; Nikiforov YE; Seethala RR
    Endocr Pathol; 2018 Sep; 29(3):242-249. PubMed ID: 29508145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of Thyroid Tumors Based on DNA Methylation Patterns.
    Marczyk VR; Recamonde-Mendoza M; Maia AL; Goemann IM
    Thyroid; 2023 Sep; 33(9):1090-1099. PubMed ID: 37392021
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg.
    Rendl G; Rodrigues M; Schweighofer-Zwink G; Hutter J; Hittmair A; Zellinger B; Hauser-Kronberger C; Pirich C
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):540-544. PubMed ID: 28493027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.
    Wallander M; Layfield LJ; Jarboe E; Emerson L; Liu T; Thaker H; Holden J; Tripp S
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):231-5. PubMed ID: 20042852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
    Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
    Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer.
    Park JL; Jeon S; Seo EH; Bae DH; Jeong YM; Kim Y; Bae JS; Kim SK; Jung CK; Kim YS
    Thyroid; 2020 Feb; 30(2):192-203. PubMed ID: 31797753
    [No Abstract]   [Full Text] [Related]  

  • 31. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Diagnostic updates and molecular advances.
    Chu YH; Sadow PM
    Semin Diagn Pathol; 2020 Sep; 37(5):213-218. PubMed ID: 32646613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
    Afkhami M; Karunamurthy A; Chiosea S; Nikiforova MN; Seethala R; Nikiforov YE; Coyne C
    Thyroid; 2016 Feb; 26(2):242-7. PubMed ID: 26422023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter.
    Repaci A; Salituro N; Vicennati V; Monari F; Cavicchi O; de Biase D; Ciarrocchi A; Acquaviva G; De Leo A; Gruppioni E; Pagotto U; Tallini G
    Endocr Pathol; 2022 Dec; 33(4):519-524. PubMed ID: 34843063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
    World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.
    Macerola E; Poma AM; Vignali P; Proietti A; Torregrossa L; Ugolini C; Basolo A; Matrone A; Elisei R; Santini F; Basolo F
    J Endocrinol Invest; 2023 Aug; 46(8):1651-1662. PubMed ID: 36749451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Indicator to Differentiate Thyroid Follicular Inclusions in Cervical Lymph Nodes from Patients with Thyroid Cancer.
    Otsubo C; Mussazhanova Z; Kurohama H; Shalgimbayeva G; Ueki N; Matsuoka Y; Madiyeva M; Sato S; Yamashita H; Nakashima M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
    Xu B; Tuttle RM; Sabra MM; Ganly I; Ghossein R
    Thyroid; 2017 May; 27(5):632-640. PubMed ID: 28049366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Activating Mutations of the
    Borrelli N; Panebianco F; Condello V; Barletta JA; Kaya C; Yip L; Nikiforova MN; Nikiforov YE
    Thyroid; 2019 Sep; 29(9):1279-1285. PubMed ID: 31407636
    [No Abstract]   [Full Text] [Related]  

  • 40. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.